Geode Capital Management
COGT icon

Geode Capital Management’s Cogent Biosciences COGT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$19.2M Buy
2,672,113
+256,259
+11% +$1.84M ﹤0.01% 1981
2025
Q1
$14.5M Buy
2,415,854
+107,345
+5% +$643K ﹤0.01% 2077
2024
Q4
$18M Buy
2,308,509
+27,716
+1% +$216K ﹤0.01% 2022
2024
Q3
$24.6M Buy
2,280,793
+300,062
+15% +$3.24M ﹤0.01% 1866
2024
Q2
$16.7M Buy
1,980,731
+203,627
+11% +$1.72M ﹤0.01% 2032
2024
Q1
$11.9M Buy
1,777,104
+48,322
+3% +$325K ﹤0.01% 2217
2023
Q4
$10.2M Buy
1,728,782
+81,536
+5% +$479K ﹤0.01% 2340
2023
Q3
$16.1M Buy
1,647,246
+136,952
+9% +$1.34M ﹤0.01% 1960
2023
Q2
$17.9M Buy
1,510,294
+191,986
+15% +$2.27M ﹤0.01% 1926
2023
Q1
$14.2M Buy
1,318,308
+95,978
+8% +$1.04M ﹤0.01% 2028
2022
Q4
$14.1M Buy
1,222,330
+47,570
+4% +$550K ﹤0.01% 2019
2022
Q3
$17.5M Buy
1,174,760
+436,836
+59% +$6.52M ﹤0.01% 1838
2022
Q2
$6.66M Buy
737,924
+141,262
+24% +$1.27M ﹤0.01% 2536
2022
Q1
$4.47M Buy
596,662
+18,293
+3% +$137K ﹤0.01% 2857
2021
Q4
$4.96M Buy
578,369
+605
+0.1% +$5.19K ﹤0.01% 2908
2021
Q3
$4.86M Buy
577,764
+3,895
+0.7% +$32.8K ﹤0.01% 2929
2021
Q2
$4.65M Buy
573,869
+326,825
+132% +$2.65M ﹤0.01% 2960
2021
Q1
$2.17M Buy
247,044
+34,690
+16% +$305K ﹤0.01% 3219
2020
Q4
$2.38M Buy
212,354
+113,733
+115% +$1.28M ﹤0.01% 2986
2020
Q3
$230K Buy
98,621
+25,167
+34% +$58.7K ﹤0.01% 3677
2020
Q2
$33K Hold
73,454
﹤0.01% 4034
2020
Q1
$30K Hold
73,454
﹤0.01% 3998
2019
Q4
$52K Hold
73,454
﹤0.01% 4080
2019
Q3
$105K Sell
73,454
-428
-0.6% -$612 ﹤0.01% 3938
2019
Q2
$193K Sell
73,882
-67,771
-48% -$177K ﹤0.01% 3798
2019
Q1
$621K Buy
141,653
+9,088
+7% +$39.8K ﹤0.01% 3345
2018
Q4
$583K Buy
132,565
+61,061
+85% +$269K ﹤0.01% 3316
2018
Q3
$736K Buy
71,504
+17,746
+33% +$183K ﹤0.01% 3330
2018
Q2
$771K Buy
+53,758
New +$771K ﹤0.01% 3285